Laobaixing Pharmacy
LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The… Read more
Market Cap & Net Worth: Laobaixing Pharmacy (603883)
Laobaixing Pharmacy (SHG:603883) has a market capitalization of $1.48 Billion (CN¥10.86 Billion) as of March 18, 2026. Listed on the SHG stock exchange, this China-based company holds position #8527 globally and #1634 in its home market, demonstrating a 1.27% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Laobaixing Pharmacy's stock price CN¥14.31 by its total outstanding shares 758890236 (758.89 Million).
Laobaixing Pharmacy Market Cap History: 2015 to 2026
Laobaixing Pharmacy's market capitalization history from 2015 to 2026. Data shows change from $3.73 Billion to $1.48 Billion (-5.45% CAGR).
Laobaixing Pharmacy Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Laobaixing Pharmacy's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.08x
Laobaixing Pharmacy's market cap is 0.08 times its annual revenue
7.95x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
3.26x
Laobaixing Pharmacy's market cap is 3.26 times its annual earnings
1.77x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.73 Billion | $4.57 Billion | $240.50 Million | 0.82x | 15.51x |
| 2016 | $2.47 Billion | $6.09 Billion | $296.90 Million | 0.40x | 8.31x |
| 2017 | $3.35 Billion | $7.50 Billion | $370.80 Million | 0.45x | 9.04x |
| 2018 | $2.54 Billion | $9.47 Billion | $435.04 Million | 0.27x | 5.85x |
| 2019 | $3.48 Billion | $11.66 Billion | $508.71 Million | 0.30x | 6.84x |
| 2020 | $4.81 Billion | $13.97 Billion | $621.09 Million | 0.34x | 7.74x |
| 2021 | $3.80 Billion | $15.70 Billion | $669.24 Million | 0.24x | 5.68x |
| 2022 | $4.11 Billion | $20.18 Billion | $784.96 Million | 0.20x | 5.24x |
| 2023 | $3.09 Billion | $22.44 Billion | $929.02 Million | 0.14x | 3.33x |
| 2024 | $1.69 Billion | $22.36 Billion | $519.06 Million | 0.08x | 3.26x |
Competitor Companies of 603883 by Market Capitalization
Companies near Laobaixing Pharmacy in the global market cap rankings as of March 18, 2026.
Key companies related to Laobaixing Pharmacy by market ranking:
- Alibaba Health Information Technology Limited (PINK:ALBBY): Ranked #1435 globally with a market cap of $12.50 Billion USD.
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #1880 globally with a market cap of $8.58 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2749 globally with a market cap of $5.08 Billion USD ( R$30.91 Billion BRL).
- Clicks Group Ltd (PINK:CLCGY): Ranked #2859 globally with a market cap of $4.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1435 | Alibaba Health Information Technology Limited | PINK:ALBBY | $12.50 Billion | $12.32 |
| #1880 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $8.58 Billion | $11.98 |
| #2749 | Raia Drogasil S.A | SA:RADL3 | $5.08 Billion | R$23.58 |
| #2859 | Clicks Group Ltd | PINK:CLCGY | $4.80 Billion | $35.11 |
Laobaixing Pharmacy Historical Marketcap From 2015 to 2026
Between 2015 and today, Laobaixing Pharmacy's market cap moved from $3.73 Billion to $ 1.48 Billion, with a yearly change of -5.45%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.48 Billion | -3.31% |
| 2025 | CN¥1.53 Billion | -9.59% |
| 2024 | CN¥1.69 Billion | -45.23% |
| 2023 | CN¥3.09 Billion | -24.83% |
| 2022 | CN¥4.11 Billion | +8.16% |
| 2021 | CN¥3.80 Billion | -20.89% |
| 2020 | CN¥4.81 Billion | +38.06% |
| 2019 | CN¥3.48 Billion | +36.89% |
| 2018 | CN¥2.54 Billion | -24.11% |
| 2017 | CN¥3.35 Billion | +35.89% |
| 2016 | CN¥2.47 Billion | -33.87% |
| 2015 | CN¥3.73 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Laobaixing Pharmacy was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.48 Billion USD |
| MoneyControl | $1.48 Billion USD |
| MarketWatch | $1.48 Billion USD |
| marketcap.company | $1.48 Billion USD |
| Reuters | $1.48 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.